NFKB1 and endometriosis: Pharmacological inhibitors targeting NFκB may serve as potential therapeutic agents, with recent research focusing on the influence of NFκB-activated macrophages on different mechanisms, and their subsequent impact on endometriosis progression by release of proinflammatory cytokines and growth factors.